NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
21 hedge funds and large institutions have $7.13M invested in NeuroMetrix, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
498% more capital invested
Capital invested by funds: $1.19M → $7.13M (+$5.94M)
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
50% more funds holding
Funds holding: 14 → 21 (+7)
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.47M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$393K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
+$341K |
| 4 |
BlackRock
New York
|
+$321K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$265K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$928K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$103K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$98K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$76.9K |
| 5 |
Morgan Stanley
New York
|
-$48.9K |
NURO Hedge Fund Activity: Q3 2021 in Review
21 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q3 2021, worth a combined $7.13M — up 498% from $1.19M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new NURO positions and 4 closed out — a net gain of 7 holders — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, adding an estimated $3.47M. The largest seller was Renaissance Technologies, cutting an estimated $928K.
- 21 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q3 2021, up from 14 in Q2 2021.
- Funds reported $7.13M of NeuroMetrix, Inc. Common Stock stock for Q3 2021, up 498% quarter-over-quarter.
- 11 funds opened new NeuroMetrix, Inc. Common Stock positions in Q3 2021 and 4 closed out, a net change of +7 holders.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q3 2021 was Vanguard Group, an estimated $3.47M added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q3 2021 was Renaissance Technologies, an estimated $928K sold.
Based on aggregated 13F filings for Q3 2021.